President Trump Unveils Major Initiatives on Drug Pricing, Gaza Peace, and TikTok's Future

On September 30, 2025, President Donald Trump enacted a series of executive actions and made pivotal announcements from the White House, impacting healthcare, foreign policy, and technology. The day's agenda included a significant drug pricing agreement with pharmaceutical giant Pfizer, the imposition of a deadline for Hamas to respond to a proposed Gaza peace plan, and further developments concerning the operation of the social media platform TikTok in the United States. Additionally, the President signed an executive order to advance artificial intelligence in pediatric cancer research.

A Landmark Agreement on Drug Pricing

President Trump announced a 'historic agreement' with Pfizer Inc. aimed at substantially lowering prescription drug costs for American patients. The deal, which followed an executive order signed in May 2025, mandates that Pfizer ensure U.S. drug prices are comparable to those in other developed nations, a concept known as 'most favored nation' (MFN) pricing. As part of the agreement, Pfizer will participate in a new direct purchasing platform, TrumpRx.gov, designed to offer medications at discounted rates directly to consumers. Savings are projected to be as high as 85% for primary care treatments, with an average discount of 50% across select brands. The pharmaceutical company also committed to a $70 billion investment in research and development and domestic manufacturing. Specific examples of direct purchase discounts include Eucrisa at 80%, Xeljanz at 40%, and Zavzpret at 50%. The announcement was made alongside Pfizer CEO Albert Bourla and U.S. Health Secretary Robert F. Kennedy Jr.

Ultimatum Issued for Gaza Peace Plan

In a significant foreign policy move, President Trump issued a 'three-to-four day' deadline for Hamas to respond to his 20-point peace plan aimed at ending the conflict in Gaza. The comprehensive proposal includes several key components:

• A immediate ceasefire.
• A hostage swap, exchanging Israeli captives held by Hamas for Palestinian prisoners held by Israel.
• A staged Israeli withdrawal from Gaza.
• The disarmament of Hamas.
• The establishment of a transitional government, referred to as a 'Board of Peace,' to oversee Gaza. This board would be chaired by President Trump, with former UK Prime Minister Tony Blair among its members.

President Trump warned that if Hamas rejects the plan, 'Israel would have my full backing to finish the job of destroying the threat of Hamas.' While Qatar's foreign ministry indicated that Hamas was 'responsibly' studying the proposal, Israeli Prime Minister Benjamin Netanyahu reportedly stated that Israel would 'forcibly resist' any pathway to Palestinian statehood outlined in the plan. Several Arab and Muslim nations have urged Hamas to accept the terms.

TikTok's Continued Operation Secured

Addressing ongoing concerns about the popular social media application, President Trump signed an executive order on September 25, 2025, allowing TikTok to continue operating in the United States. This action followed a deal reached after discussions with China's president. The agreement stipulates that TikTok's U.S. operations will be managed by a joint venture, with a majority stake held by U.S. investors, and ByteDance, TikTok's parent company, retaining less than 20% ownership. Oracle, a U.S. technology company, is slated to independently monitor TikTok's operations to address national security concerns. This executive order marks a continuation of previous reprieves, with the President having formally extended the deadline for TikTok to sell its assets or face a ban until December 16, 2025, on September 16, 2025. This was the fourth such extension since the original ban deadline of January 19, 2025.

Advancing AI in Pediatric Cancer Research

In a separate executive order signed on September 30, 2025, President Trump initiated a new effort to harness American AI innovation for pediatric cancer research. The order directs the MAHA Commission to utilize artificial intelligence to transform cancer care and research. This initiative includes doubling federal investment in the Childhood Cancer Data Initiative with an additional $50 million, aiming to build stronger data systems, decode complex biology, and design more effective clinical trials for children.

The series of announcements and executive orders underscore a busy day for the administration, touching upon diverse and impactful policy areas.